By downregulating C/EBPβ, the expression of NLRP3 and other inflammasome components is reduced, thereby attenuating the inflammatory response and mitigating neuronal damage in an MPTP neurotoxic model of PD (55, 95). This evidence concerns the gene CEBPB and Parkinson disease.